Are Third Parties Pharmaceutical Companies’ Achilles’ Heel?
For pharmaceutical and life science firms there has been nothing like the past 18 months. Faced with a 100-year pandemic that demanded unprecedented speeds in research and development while working under conditions that were unusual to say the least, these companies have had to collaborate with each other and with third parties as never before. […]
